Furthermore, in the rat model of high pulmonary blood flow-induced pulmonary hypertension by surgical systemic-pulmonary shunting, the activated TGF-β1/Smad2/3 pathway could be inhibited by the administration of SO2 derivatives [46]. Here, SMAD2 is linked to pulmonary arterial hypertension.